In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Dopamini hydrochloridum,(S) Drug Master File in Korea (Dopamini hydrochloridum,(S) KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Dopamini hydrochloridum,(S). The MFDS reviews the Dopamini hydrochloridum,(S) KDMF as part of the drug registration process and uses the information provided in the Dopamini hydrochloridum,(S) KDMF to evaluate the safety and efficacy of the drug.
After submitting a Dopamini hydrochloridum,(S) KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Dopamini hydrochloridum,(S) API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Dopamini hydrochloridum,(S) suppliers with KDMF on PharmaCompass.